Royce & Associates LP Purchases 43,000 Shares of Celsius Holdings, Inc. (NASDAQ:CELH)

Royce & Associates LP lifted its holdings in Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) by 505.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 51,500 shares of the company's stock after buying an additional 43,000 shares during the quarter. Royce & Associates LP's holdings in Celsius were worth $1,357,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. HM Payson & Co. boosted its position in shares of Celsius by 122.2% in the 4th quarter. HM Payson & Co. now owns 1,000 shares of the company's stock worth $26,000 after purchasing an additional 550 shares in the last quarter. S.A. Mason LLC grew its stake in shares of Celsius by 100.0% in the fourth quarter. S.A. Mason LLC now owns 1,400 shares of the company's stock worth $37,000 after acquiring an additional 700 shares during the last quarter. Activest Wealth Management purchased a new stake in shares of Celsius in the third quarter worth $39,000. GAMMA Investing LLC increased its holdings in shares of Celsius by 185.7% during the fourth quarter. GAMMA Investing LLC now owns 1,714 shares of the company's stock valued at $45,000 after acquiring an additional 1,114 shares in the last quarter. Finally, Blue Trust Inc. boosted its stake in Celsius by 32.8% in the 4th quarter. Blue Trust Inc. now owns 1,786 shares of the company's stock worth $47,000 after purchasing an additional 441 shares in the last quarter. 60.95% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on CELH. TD Cowen lowered shares of Celsius from a "buy" rating to a "hold" rating and reduced their price objective for the company from $40.00 to $29.00 in a research note on Wednesday, January 22nd. UBS Group lowered their price objective on Celsius from $45.00 to $39.00 and set a "buy" rating on the stock in a research report on Thursday, January 16th. Jefferies Financial Group cut their target price on Celsius from $44.00 to $40.00 and set a "buy" rating on the stock in a research note on Thursday, December 19th. Needham & Company LLC upped their price target on Celsius from $38.00 to $40.00 and gave the company a "buy" rating in a report on Tuesday, February 25th. Finally, Piper Sandler reduced their price objective on Celsius from $47.00 to $33.00 and set an "overweight" rating for the company in a report on Thursday, January 23rd. One research analyst has rated the stock with a sell rating, five have issued a hold rating and eleven have issued a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $45.00.

Remove Ads

Celsius Price Performance

Shares of CELH stock traded up $0.38 during trading hours on Tuesday, reaching $35.26. 7,682,399 shares of the company traded hands, compared to its average volume of 7,349,505. The firm has a 50-day moving average price of $26.26 and a 200 day moving average price of $28.71. The company has a market cap of $8.29 billion, a P/E ratio of 80.14, a P/E/G ratio of 2.90 and a beta of 1.90. Celsius Holdings, Inc. has a 12-month low of $21.10 and a 12-month high of $98.85.

Celsius (NASDAQ:CELH - Get Free Report) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.14 earnings per share for the quarter, topping analysts' consensus estimates of $0.11 by $0.03. Celsius had a net margin of 10.70% and a return on equity of 51.89%. The business had revenue of $332.20 million during the quarter, compared to analyst estimates of $326.07 million. Sell-side analysts predict that Celsius Holdings, Inc. will post 0.89 EPS for the current year.

Insider Buying and Selling at Celsius

In related news, insider Paul H. Storey sold 10,188 shares of the business's stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $25.77, for a total value of $262,544.76. Following the transaction, the insider now directly owns 45,297 shares of the company's stock, valued at approximately $1,167,303.69. The trade was a 18.36 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Joyce Russell sold 4,000 shares of the stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $28.47, for a total transaction of $113,880.00. Following the sale, the director now directly owns 19,106 shares of the company's stock, valued at approximately $543,947.82. This trade represents a 17.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.20% of the company's stock.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.